ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+18.17%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$312M
AUM Growth
+$52.9M
(+20%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-494.75%
Top 10 Holdings %
Top 10 Hldgs %
58.24%
Holding
72
New
22
Increased
15
Reduced
13
Closed
19
Top Buys
| 1 |
Elevance Health
ELV
|
$17M |
| 2 |
Encompass Health
EHC
|
$10.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$10.3M |
| 4 |
SI-BONE Inc
SIBN
|
$10.1M |
| 5 |
Cencora
COR
|
$9.63M |
Top Sells
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$27.7M |
| 2 |
HCA Healthcare
HCA
|
$18M |
| 3 |
Johnson & Johnson
JNJ
|
$13.9M |
| 4 |
Charles River Laboratories
CRL
|
$9.93M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$8.84M |
Sector Composition
| 1 | Healthcare | 90.71% |
| 2 | Industrials | 1.02% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
26
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.19M | 1.01% |
246,029
-2,132,934
| -90% | -$27.7M |
|
|
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.11M | 0.98% |
29,710
+12,580
| +73% | +$1.32M |
|
28
Baxter International
BAX
$12.1B
| $2.86M | 0.9% |
+34,151
| New | +$2.86M |
|
29
Fate Therapeutics
FATE
$112M
| $2.64M | 0.83% |
135,022
-31,760
| -19% | -$621K |
|
30
Adverum Biotechnologies
ADVM
$66.5M
| $2.48M | 0.78% |
+21,482
| New | +$2.48M |
|
|
SILK
31
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.07M | 0.65% |
+51,303
| New | +$2.07M |
|
32
CONMED
CNMD
$1.69B
| $2.01M | 0.63% |
17,940
+4,828
| +37% | +$540K |
|
33
AdaptHealth
AHCO
$1.25B
| $1.84M | 0.58% |
+167,858
| New | +$1.84M |
|
34
Prothena Corp
PRTA
$442M
| $1.74M | 0.55% |
110,135
+23,728
| +27% | +$376K |
|
35
McKesson
MCK
$86B
| $1.44M | 0.45% |
+10,396
| New | +$1.44M |
|
36
Liquidia Corp
LQDA
$2.48B
| $1.36M | 0.43% |
317,993
| – | – |
|
37
MacroGenics
MGNX
$123M
| $1.34M | 0.42% |
+122,900
| New | +$1.34M |
|
38
Tandem Diabetes Care
TNDM
$837M
| $1.27M | 0.4% |
+21,361
| New | +$1.27M |
|
39
Axsome Therapeutics
AXSM
$6.21B
| $1.15M | 0.36% |
+11,151
| New | +$1.15M |
|
40
DaVita
DVA
$9.69B
| $901K | 0.28% |
+12,002
| New | +$901K |
|
|
NCNA
41
NuCana
NCNA
$5.46M
| $666K | 0.21% |
22
-55
| -71% | -$1.67M |
|
42
Apellis Pharmaceuticals
APLS
$3.62B
| $593K | 0.19% |
19,362
-2,919
| -13% | -$89.4K |
|
|
SDC
43
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $517K | 0.16% |
59,178
-74,210
| -56% | -$648K |
|
|
GNCA
44
DELISTED
Genocea Biosciences, Inc.
GNCA
| $493K | 0.16% |
238,207
+50,079
| +27% | +$104K |
|
45
Sutro Biopharma
STRO
$86.5M
| $359K | 0.11% |
+32,666
| New | +$359K |
|
|
WMGI
46
DELISTED
Wright Medical Group Inc
WMGI
| $356K | 0.11% |
11,669
-289,722
| -96% | -$8.84M |
|
|
DRNA
47
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $303K | 0.1% |
+13,768
| New | +$303K |
|
48
Actinium Pharmaceuticals
ATNM
$52.7M
| $147K | 0.05% |
22,570
-22,569
| -50% | -$147K |
|
49
Cartesian Therapeutics
RNAC
$260M
| $61K | 0.02% |
+860
| New | +$61K |
|
50
Acadia Healthcare
ACHC
$2.18B
| – | – |
-23,918
| Closed | -$743K |
|